GSK Clinical Trials

Clinical trials sponsored by GSK — phases, conditions and reported results. Data from ClinicalTrials.gov.

• Study to Evaluate the Safety and Efficacy of GSK1278863 in Recombinant Human Erythropoietin (rhEPO) Hyporespon
  Phase 2 · Anemia · Terminated · Jun 21, 2017
• A First Time in Human (FTIH) Study of GSK3745417 Administered to Participants With Advanced Solid Tumors
  Phase 1 · Neoplasms · Terminated · Jan 8, 2026
• Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patien
  Phase 1/2 · Urothelial Carcinoma · Terminated · Aug 3, 2026
• Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivi
  Phase 3 · HIV Infections · Active, not recruiting · Oct 29, 2019
• Safety and Immunogenicity of Clade C ALVAC and gp120 HIV Vaccine
  Phase 1/2 · HIV Infections · Completed · Feb 18, 2021
• Effect of Mepolizumab in Severe Bilateral Nasal Polyps
  Phase 3 · Nasal Polyps · Completed · Dec 17, 2020
• Efficacy and Safety of Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)/ Eosinophi
  Phase 3 · Nasal Polyps · Completed · Nov 25, 2024
• Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN)
  Phase 3 · Pruritus · Completed · Jul 22, 2025
• A Study of Safety and Immune Response to Different Doses of a Cytomegalovirus Vaccine in Healthy Adults
  Phase 1/2 · Cytomegalovirus Infections · Completed · Jul 17, 2026
• Immunogenicity, Safety, Reactogenicity and Persistence of an Investigational Respiratory Syncytial Virus (RSV)
  Phase 3 · Respiratory Syncytial Virus Infections · Active, not recruiting · Dec 21, 2023
• Study to Evaluate the Effect of Bepirovirsen on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in
  Phase 1 · Hepatitis B · Completed · Jul 10, 2026
• Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-act
  Phase 3 · Infection, Human Immunodeficiency Virus · Active, not recruiting · Jun 13, 2019
• Study in Pediatrics With HypEREosinophilic Syndrome (SPHERE)
  Phase 3 · Hypereosinophilic Syndrome · Completed · May 4, 2026
• Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Pa
  Phase 2/3 · Lung Cancer, Non-Small Cell · Active, not recruiting · Jul 1, 2026
• Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Partic
  Phase 3 · Multiple Myeloma · Active, not recruiting · Oct 6, 2023

Trials by company

PfizerMerck (MSD)RocheNovartisAstraZenecaJohnson & Johnson (Janssen)Bristol Myers SquibbSanofiGSKEli LillyAbbVieAmgenBayerBoehringer IngelheimNovo NordiskTakedaGilead SciencesModernaBioNTechRegeneronVertexBiogenDaiichi SankyoAstellas PharmaEisaiOtsukaServierIncyteCelltrionSamsung BioepisHanmi PharmaceuticalYuhan

All trials